First, these studies were not specifically designed to evaluate the risk of gallbladder or biliary diseases associated with GLP-1 Ras treatment, further validation could be done in future by designing large clinical studies with stroke as an endpoint. The gene discussed is GLP1R; the disease is Stroke.